Fabrice Barlési - Publications, H-index & Citations

Fabrice Barlési

gustave roussy

99H指数

1.5K论文数

7.1W被引数

收录论文 307

发表时间

Plain language summary of the KRYSTAL-12 study results: adagrasib for non−small cell lung cancer with KRASG12C mutations KRYSAL-12研究的通俗结果摘要：针对KRASG12C突变的非小细胞肺癌的adagrasib治疗

Future Oncology

IF2.6

2026-09-16

OAAI

Fabrice Barlesi; Wenxiu Yao; Michaël Duruisseaux; Ludovic Doucet; Aitor Azkárate Martínez; Vanesa Gregorc; Oscar Juan-Vidal; Shun Lu; Charlotte De Bondt; Filippo de Marinis; Helena Linardou; Young-Chul Kim; Robert Jotte; Enriqueta Felip; Giuseppe Lo Russo; Martin Reck; Mary F MichenzIe; Wenjing Yang; Julie N Meade; Beata Korytowsky; Tony S K Mok; null

Patient-reported outcomes with adagrasib in KRYSTAL-12 阿达格拉西布在KRYSTAL-12研究中的患者报告结局

The Lancet

IF88.5

2026-08-20

PREAI

Fabrice Barlesi; Enriqueta Felip; Tony S K Mok

First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet need KRAS突变晚期非小细胞肺癌患者的一线治疗模式及真实世界结局（存在高未满足需求）

Lung Cancer

IF4.4

2026-05-25

PREAI

Fabrice Barlesi; Ferdinandos Skoulidis; Benjamin Solomon; Joowon Lee; Rami Jassim; Ravi Gupta; Marco Mesa-Frias; Enriqueta Felip

Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts 肿瘤学中的放射性药物疗法：来自大西洋两岸专家的视角

Oncology and Therapy

IF3.2

2026-04-05

OAAI

Désirée Deandreis; Heather Jacene; Patrick Therasse; Fabrice André; Fabrice Barlesi; Kevin Haigis; Karim Fizazi; Toni K. Choueiri

Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer ALINA研究结果的大众语言摘要：alectinib与化疗相比，在ALK阳性非小细胞肺癌患者术后的应用

Future Science OA

IF2.1

2025-12-31

PREAI

Wu, Yi-Long; Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Nishio, Makoto; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; De Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Lu, Shun; Wang, Qun; Lohmann, Tania Ochi; Xu, Tingting; Cardona, Andres; Hiles, Laura; Noe, Johannes; Solomon, Benjamin J.

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations 非小细胞肺癌分子亚型和免疫治疗组合的脆弱性

Nature Communications

IF15.7

2025-12-03

OAAI

Tianshi Lu; Habib Hamidi; Mark A. Socinski; Martin Reck; Federico Cappuzzo; Fabrice Barlesi; Robert M. Jotte; Sören Müller; Aditi Qamra; Assaf Amitai; Xiangnan Guan; Eloisa Fuentes; Hartmut Koeppen; Jennifer M. Giltnane; David S. Shames; Marcus Ballinger; Meng Xiao He; Yulei Wang; Minu K. Srivastava; Barzin Y. Nabet

Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients 肛门鳞状细胞癌的全面分子图谱：1844例患者的组织活检和液体活检分析

npj Precision Oncology

IF8

2025-11-24

OAAI

Cristina Smolenschi; Saumya D. Sisoudiya; Antoine Hollebecque; Smruthy Sivakumar; Meagan Montesion; Victor Euzen; Valérie Boige; Alice Boilève; Marine Valery; Isabelle Sourouille; Arnaud Bayle; Mihaela Aldea; Julieta Elena Rodriguez; Massimiliano Gelli; Filippo Gustavo Dall’Olio; Anthony Tarabay; Thomas Pudlarz; Rastislav Bahleda; Alina Fuerea; Léonor Benhaim; Elena Fernandez de Sevilla; Mohamed Bani; Peggy Dartigues; Simon Pernot; Gautier Boillet; Kristi Beshiri; Christophe Massard; Luc Friboulet; Francesco Facchinetti; Ludovic Lacroix; Etienne Rouleau; Fabrice Barlesi; Michel Ducreux; Antoine Italiano; Radwa Sharaf; Damien Vasseur

Efficacy of neratinib-based therapy in ERBB2-mutant lung adenocarcinomas: findings from 2 international phase 2 studies 奈拉替尼为基础疗法在ERBB2突变型肺腺癌中的疗效：2项国际II期研究的结果

Clinical Lung Cancer

IF3.3

2025-10-01

PREAI

Bob T. Li; Leena Gandhi; Vignesh Ravichandran; Benjamin Besse; Julien Mazières; Geoffrey I. Shapiro; Valentina Boni; Saiama N. Waqar; Haeseong Park; David I. Quinn; Alejandro Martinez; Salomon M. Stemmer; Alexis B. Cortot; Fabrice Barlesi; Elisabeth Quoix; Mark E. Burkard; S. Duygu Selcuklu; Casey Hunt; Mark T.A. Donoghue; Mark G. Kris; Judith Bebchuk; Lisa D. Eli; Leanne McCulloch; David B. Solit; Pasi A. Jänne

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†早期和局部晚期非小细胞肺癌：ESMO 临床实践指南（用于诊断、治疗和随访）†

Annals of Oncology

IF65.4

2025-08-28

PREAI

A. Zer; M.-J. Ahn; F. Barlesi; L. Bubendorf; D. De Ruysscher; P. Garrido; O. Gautschi; L.E. Hendriks; P.A. Jänne; K.M. Kerr; C. Mascaux; T. Mitsudomi; S. Peters; C. Rolfo; A. Sacher; S. Senan; P. Ugalde; N.B. Leighl

Treatment of NSCLC after chemoimmunotherapy — are we making headway?化疗免疫疗法后的NSCLC治疗——我们是否取得了进展？

Nature Reviews Clinical Oncology

IF82.2

2025-08-14

PREAI

Martin Reck; Nikolaj Frost; Solange Peters; Bernard A. Fox; Roberto Ferrara; Rajkumar Savai; Fabrice Barlesi

Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial Adagrasib 与多西他赛在 KRASG12C 突变非小细胞肺癌中的比较（KRYSTAL-12）：一项随机、开放标签、III 期临床试验

lancet

IF0

2025-08-07

PREAI

Fabrice Barlesi; Wenxiu Yao; Michaël Duruisseaux; Ludovic Doucet; Aitor Azkárate Martínez; Vanesa Gregorc; Oscar Juan-Vidal; Shun Lu; Charlotte De Bondt; Filippo de Marinis; Helena Linardou; Young-Chul Kim; Robert Jotte; Enriqueta Felip; Giuseppe Lo Russo; Martin Reck; Mary F Michenzie; Wenjing Yang; Julie N Meade; Beata Korytowsky; Tony S K Mok

The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients 液体活检基因组数据与结直肠癌、胰腺癌、肺癌和前列腺癌患者影像组学之间的相关性

European Journal of Cancer

IF7.1

2025-07-08

PREAI

Antoine Italiano; Othilie Gautier; Jules Dupont; Tarek Assi; Lama Dawi; Littisha Lawrance; Alexandre Bone; Ghina Jardali; Aurelie Choucair; Samy Ammari; Arnaud Bayle; Etienne Rouleau; Paul Henry Cournede; Isabelle Borget; Benjamin Besse; Fabrice Barlesi; Christophe Massard; Nathalie Lassau

Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer 基线CT测量的肿瘤负荷和液体活检作为预测转移性实体癌患者生存的生物标志物

Diagnostic and Interventional Imaging

IF8.1

2025-06-08

PREAI

Ghina Jardali; Littisha Lawrance; Lama Dawi; Jules Dupont; Othilie Gautier; Michèle Kind; Samy Ammari; Joya Hadchiti; Aurélie Choucair; Arnaud Bayle; Paul-Henry Cournède; Isabelle Borget; Serge Muller; François Bidault; Corinne Balleyguier; Antoine Hollebecque; Yohann Loriot; Filippo Gustavo Dall-Olio; Benjamin Besse; Ludovic Lacroix; Etienne Rouleau; Alexandre Bône; Fabrice André; Christophe Massard; Fabrice Barlesi; Antoine Italiano; Nathalie Lassau

Real-world characteristics and survival outcomes of patients with metastatic ALK fusion-positive solid tumors treated with standard-of-care therapies 真实世界中接受标准护理治疗的患者，其ALK融合阳性转移性实体瘤的临床特征和生存结局

ONCOLOGIST

IF4.2

2025-05-08

OAAI

Gadgeel, Shirish M.; Fajardo, Otto; Barlesi, Fabrice; Kim, Jeong Eun; Kurzrock, Razelle; Thomas, David M.; Jagtiani, Ritika; Noe, Johannes; Schwemmers, Sven; Nikolaidis, Christos

Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer EVIDENS研究（一项关于纳武利尤单抗治疗非小细胞肺癌的观察性研究）的最终3年结果

OncoImmunology

IF6.3

2025-04-15

OAAI

Fabrice Barlesi; Adrien Dixmier; Didier Debieuvre; Christophe Raspaud; Jean-Bernard Auliac; Nicolas Benoit; Pierre Bombaron; Denis Moro-Sibilot; Bernard Asselain; Clarisse Audigier-Valette; Florence Brellier; François-Emery Cotté; Yaacoub Khalife; Maurice Pérol

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers 与晚期癌症生存相关的肠道功能障碍的替代标志物

OncoImmunology

IF6.3

2025-04-06

OAAI

Roxanne Birebent; Damien Drubay; Carolina Alves Costa Silva; Federica Marmorino; Giacomo Vitali; Gianmarco Piccinno; Yoan Hurtado; Adele Bonato; Lorenzo Belluomini; Meriem Messaoudene; Bertrand Routy; Marine Fidelle; Gerard Zalcman; Julien Mazieres; Clarisse Audigier-Valette; Denis Moro-Sibilot; François Goldwasser; Arnaud Scherpereel; Hervé Pegliasco; François Ghiringhelli; Anna Reni; Fabrice Barlesi; Laurence Albiges; David Planchard; Stéphanie Martinez; Benjamin Besse; Nicola Segata; Chiara Cremolini; Laurence Zitvogel; Valerio Iebba; Lisa Derosa

Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From the REISAMIC Registry T细胞接合剂作为癌症免疫疗法治疗患者的感染并发症：一项来自REISAMIC登记研究的描述性研究

CLINICAL INFECTIOUS DISEASES

IF7.3

2025-04-01

PREAI

Hueso, Thomas; Cagnat, Justin; Ouali, Kaissa; Haberstich, Mathilde; Henry, Benoit; Danu, Alina; Bigenwald, Camille; Merad, Mansouria; Messayke, Sabine; Laparra, Ariane; Sakkal, Madona; Smolenschi, Cristina; Hollebecque, Antoine; Gazzah, Anas; Baldini, Capucine; Bahleda, Rastislav; Besse, Benjamin; Rigaud, Charlotte; Minard-Colin, Veronique; Ribrag, Vincent; Laghouati, Salim; Chachaty, Elisabeth; Barlesi, Fabrice; Marabelle, Aurelien; Lambotte, Olivier; Massard, Christophe; Michot, Jean-Marie

Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives

CANCER TREATMENT REVIEWS

IF10.5

2024-12-01

PREAI

Parisi, Claudia; Abdayem, Pamela; Tagliamento, Marco; Besse, Benjamin; Planchard, David; Remon, Jordi; Minuti, Gabriele; Cappuzzo, Federico; Barlesi, Fabrice

Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2024-11-28

OAAI

Dall'Olio, Filippo G.; Zrafi, Wael Salem; Blampey, Quentin; Danlos, Francois-Xavier; Roulleaux-Dugage, Matthieu; Roman, Gabriel; Naltet, Charles; Cournede, Paul-Henry; Gautheret, Daniel; Aldea, Mihaela; Planchard, David; Barlesi, Fabrice; Marabelle, Aurelien; Hulett, Tyler; Chaput-Gras, Nathalie; Besse, Benjamin

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (vol 24, 1307, 2024)

BMC CANCER

IF3.4

2024-11-21

OAAI

Santoro, Armando; Pilar, Garrido; Tan, Daniel S. W.; Zugazagoitia, Jon; Shepherd, Frances A.; Bearz, Alessandra; Barlesi, Fabrice; Kim, Tae Min; Overbeck, Tobias R.; Felip, Enriqueta; Cai, Can; Eddy, Simantini; Mcculloch, Tracey; Schaefer, Eric S.

研究方向